transforming-growth-factor-beta has been researched along with Muscular-Atrophy--Spinal* in 2 studies
2 other study(ies) available for transforming-growth-factor-beta and Muscular-Atrophy--Spinal
Article | Year |
---|---|
Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy.
Spinal and bulbar muscular atrophy (SBMA) is a late-onset lower motor neuron disease caused by the expansion of a trinucleotide CAG repeat, which encodes a polyglutamine tract in androgen receptor (AR). Although it is commonly held that the pathogenic polyglutamine proteins accumulate in neurons and thereby induce transcriptional dysregulation, the downstream molecular events have remained elusive. Here, we examined whether TGF-beta signaling is dysregulated in SBMA. Nuclear translocation of phosphorylated Smad2/3, a key step in TGF-beta signaling, is suppressed in the spinal motor neurons of male transgenic mice carrying the mutant human AR. A similar finding was also observed in the motor neurons, but not in Purkinje cells, of SBMA patients. The pathogenic AR, the causative protein of SBMA, inhibits the transcription of TGF-beta receptor type II (TbetaRII) via abnormal interactions with NF-Y and p300/CBP-associated factor. Furthermore, overexpression of TbetaRII dampens polyglutamine-induced cytotoxicity in a neuroblastoma cell line expressing the pathogenic AR. The present study thus indicates that disruption of TGF-beta due to the transcriptional dysregulation of TbetaRII is associated with polyglutamine-induced motor neuron damage in SBMA. Topics: Aged; Animals; Humans; Male; Mice; Mice, Transgenic; Middle Aged; Motor Neurons; Muscular Atrophy, Spinal; Muscular Disorders, Atrophic; Nerve Degeneration; Signal Transduction; Transforming Growth Factor beta | 2010 |
Transforming growth factor-beta2 is elevated in skeletal muscle disorders.
The transforming growth factor betas (TGF-betas) are multifunctional growth factors that act on both fibroblasts and myosatellite cells. In rodent models of muscle diseases, high levels of TGF-beta2 are expressed by myogenic cells. We have examined whether the expression of TGF-beta2 is also elevated in diseased human muscles. The disorders examined were Duchenne muscular dystrophy, myotonic dystrophy, myotubular myopathy, spinal muscular atrophy, and amyotrophic lateral sclerosis. The levels of TGF-beta2 immunoreactivity were elevated in atrophic, necrotic, and regenerating fibers and in fibers with central nuclei or cytoplasmic masses, irrespective of whether fibrosis was present. We therefore suggest that TGF-beta2 is important for muscle repair and that the presence of a TGF-beta within a muscle only leads to fibrosis if certain other factors are present. Topics: Amyotrophic Lateral Sclerosis; Animals; Biopsy; Case-Control Studies; Desmin; Humans; Immunohistochemistry; Microscopy, Immunoelectron; Muscle, Skeletal; Muscular Atrophy, Spinal; Muscular Diseases; Muscular Dystrophies; Rats; Species Specificity; Transforming Growth Factor beta | 1999 |